Usc Atri
Business Services · United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.actcinfo.orgRevenue
<$5 MillionIndustry
About Usc Atri
Usc Atri Org Chart
Is Usc Atri your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Usc Atri has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Usc Atri recently announced quarterly report
Usc Atri, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Usc Atri is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Usc Atri
Funding: Get notified immidiatlly once Usc Atri has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Usc Atri launches new products
Click to see if Usc Atri had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Usc Atri
Compare insights from companies similar to Usc Atri, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Usc Atri is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Usc Atri is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Usc Atri.
Usc Atri Tech Stack
A closer look at the technologies used by Usc Atri
Usc Atri News & Media
Initiation Of New Phase III Clinical Study (AHEAD 3-45) Of BAN2401 Preclinical (Asymptomatic) Alzheimer's Disease
TOKYO and CAMBRIDGE, Mass., July 13, 2020 /PRNewswire/ -- The Alzheimer's Clinical Trials Consortium (ACTC), Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai"), and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, Massachusetts, United States, CEO: Michel Vounatsos,...Cognition Therapeutics Receives $75.8 Million NIA Grant for 540-Patient Phase 2 Study of CT1812 in Collaboration with the Alzheimer's Clinical Trials Consortium
New York, June 08, 2020 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the protection and restoration of synaptic function in Alzheimer’s disease and other neurodegenerative disorders, today announced that the National Institute on Aging (NIA) of the National Institutes of Health (NIH) has awarded the Company a grant (number R01AG065248) expected to total $75.8 million over five years to support a 540-patient Phase 2 study of CT1812 in individu
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Usc Atri
The Alzheimer's Clinical Trials Consortium (ACTC) is dedicated to fostering collaboration and driving innovation in research for Alzheimer's disease and related dementias (ADRD). They provide support in trial feasibility, optimization, and protocol development, ensuring inclusive and robust research practices. ACTC partners with researchers to refi... Read More